FDA Panel Backs First-in-Class Medication for Peanut Allergy FDA Panel Backs First-in-Class Medication for Peanut Allergy

An FDA advisory panel recommended peanut allergen powder (Palforzia, Aimmune Therapeutics) for children aged 4 years through 17 years who are allergic to peanuts.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news